Appendix 1: Conference program

Appendix 2: Official representatives and committees

Organising committee

Professor Andrew McLachlan, University of Sydney, Australia (Chair)
Dr Henk Bekedam, Western Pacific Regional Office, World Health Organization, Philippines
Dr Jonathan Dartnell, NPS MedicineWise, Australia
Associate Professor David Newby, University of Newcastle, Australia
Dr Jane Robertson, University of Newcastle, Australia
Dr Budiono Santoso, Western Pacific Regional Office, World Health Organization, Philippines
Emeritus Professor Tony Smith, University of Newcastle, Australia
Representatives from the Australian Government Department of Health and Ageing
Lidia Dalton, Expert Events, Australia

Scientific program committee

Dr Jane Robertson, University of Newcastle, Australia (Chair)
Emeritus Professor Lloyd Sansom, University of South Australia (Co-Chair), Former Chair of Pharmaceutical Benefits Advisory Committee, Australia
Dr Henk Bekedam, Western Pacific Regional Office, World Health Organization, Philippines
Dr Jonathan Dartnell, NPS MedicineWise, Australia
Professor Ric Day, University of New South Wales, Australia
Dr Ken Harvey, La Trobe University, Australia
Dr Kathleen Holloway, South East Asia Regional Office, World Health Organization, India
Dr Richard Laing, World Health Organization, Switzerland
Dr Mary Murray, International consultant on national medicines policies, and ReAct – Action on Antibiotic Resistance
Dr Budiono Santoso, Western Pacific Regional Office, World Health Organization, Philippines
Emeritus Professor Tony Smith, University of Newcastle, Australia
Dr Krisantha Weerasuriya, World Health Organization, Switzerland

International reference panel

Dr Budiono Santoso, Western Pacific Regional Office, World Health Organization, Philippines (Chair)
Emeritus Professor Tony Smith, University of Newcastle, Australia (Co-Chair)
Dr Palitha Abeykoon, World Health Organization, Sri Lanka
Professor Kumud Kafle, TU Teaching Hospital, Kathmandu, Nepal
Professor Kazuko Kimura, Kanazawa University, Japan
Professor Soonman Kwon, Seoul National University, South Korea
Dr Hélène Moller, UNICEF, Denmark
Dr Dennis Ross-Degnan, Harvard University, USA
Dr Amit Sengupta, People’s Health Movement, India
Dr Lucky Slamet, National Agency of Drug and Food Control, Indonesia
Dr Beverley Snell, Burnet Institute, Australia
Dr Göran Tomson, Karolinska Institute, Sweden
Dr Anita Wagner, Harvard Medical School, and Yong Loo Lin School of Medicine, Singapore
Dr Brenda Waning, UNITAID, Switzerland
Dr Peter Zinck, United Nations Population Fund, Fiji

Pharmaceutical industry reference panel

Professor Ric Day (Chair), University of New South Wales, Australia
Dr Alex Condoleon, Sanofi Australia and New Zealand
Mr Will Delaat, Australia, Former Chair of Medicines Australia, Former Chief Executive Officer of Merck Sharp and Dohme Australia
Dr David Grainger, Eli Lilly, Australia
Dr Eugene Salole, Pfizer Australia
Dr Brendan Shaw, Medicines Australia
Dr Edmund Tsuei, Asia Pacific Medicine Development Consulting, Australia


Return to: Asia Pacific Conference on National Medicines Policies

Appendix 3: Conference participant list

Last Name First Name Organisation Country
Abeykoon Palitha World Health Organization SRI LANKA
Ahaditomo Tom Indonesia Apoteker Association INDONESIA
Ahmad Hassali Mohamed Azmi Universiti Sains Malaysia MALAYSIA
Ala Ma, Virginia Department of Health PHILIPPINES
Anggriani Yusi University of Pancasila INDONESIA
Arnold Megan Ministry of Health - Tonga AUSTRALIA
Athuraliya Nimmi University of Newcastle AUSTRALIA
Azad Md. Abul Kalam Directorate General of Drug Administration BANGLADESH
Babar Zaheer-Ud-Din University of Auckland NEW ZEALAND
Bae Green Health Insurance Review and Assessment Service REPUBLIC OF KOREA
Bahri Salmah Ministry of Health MALAYSIA
Balasubramaniam Ramasamy University of Colombo SRI LANKA
Banerjee Tarak Das Community Development Medicinal Unit INDIA
Bankar Mangesh Government Medical College INDIA
Bannenberg Wilbert Mongolian Drug Safety Project/HERA NETHERLANDS
Bappukunju Ekbal Peoples Health Movement (Jan Swasthya Abhiyan-JSA) INDIA
Bekedam Henk World Health Organization PHILIPPINES
Beneragama Hemantha National Drugs Regulatory Authority SRI LANKA
Bennett Carol Consumers Health Forum of Australia AUSTRALIA
Bissell Karen International Union Against Tuberculosis and Lung Disease FRANCE
Bradley Michelle Department of Health and Ageing AUSTRALIA
Brown Andrew University of Canberra AUSTRALIA
Cai Liping Ministry of Health PEOPLE'S REPUBLIC OF CHINA
Caughey Gillian University of South Australia AUSTRALIA
Chai Michael ReAct – Action on Antibiotic Resistance MALAYSIA
Chang John Federation of Asian Pharmaceutical Associations MALAYSIA
Cheung Wai Lun Hong Kong Hospital Authority PEOPLE'S REPUBLIC OF CHINA
Chimedtseren Munkhdelger Ministry of Health MONGOLIA
Choi Nam-Kyong Seoul National University Hospital REPUBLIC OF KOREA
Chokshi Maulik Public Health Foundation INDIA
Choong Chih Tzer Health Sciences Authority SINGAPORE
Chowdhury Zafrullah Gonoshasthaya Kendra BANGLADESH
Comans Sarah Merck Serono Australia AUSTRALIA
Dalmacion Godofreda University of the Philippines PHILIPPINES
Dartnell Jonathan NPS MedicineWise AUSTRALIA
Day Richard St Vincent's Hospital AUSTRALIA
de Rosas-Valera Madeleine Department of Health PHILIPPINES
Dean Rebecca Department of Health and Ageing AUSTRALIA
Dela Paz Edelina Health Action Information Network PHILIPPINES
Delaat Will Pharmaceutical Industry AUSTRALIA
Djojodibroto Joep RS Grhasia Provinsi DIY INDONESIA
Dorji Sonam Drug Regulatory Authority BHUTAN
Dowden John Australian Prescriber AUSTRALIA
Duong Mai University of Sydney AUSTRALIA
Elisala Natano Ministry of Health TUVALU
Escalante Socorro World Health Organization VIETNAM
Faaiuaso Evelyn Ahhing LBJ Tropical Medical Center AMERICAN SAMOA
Farooqui Habib Public Health Foundation INDIA
Forzley Michele Widener School of Law USA
Fujihara Hidenori Japan Pharmaceutical Association JAPAN
Galang Rainier National Drug Information Center PHILIPPINES
Galbadrakh Nomin State Implementing Agency of Health MONGOLIA
Gazarian Madlen University of New South Wales AUSTRALIA
Geer M Ishaq University of Kashmir INDIA
Ghaokabosa Doreen Ministry of Health & Medical Services SOLOMON ISLANDS
Gill Anthony Therapeutic Goods Administration AUSTRALIA
Gloor Reiner Pharmaceutical & Healthcare Association PHILIPPINES
Gomez Marsha Pharmacy Guild of Australia AUSTRALIA
Gonzales Mimiel Department of Health and Ageing AUSTRALIA
Greig Christine Sanofi AUSTRALIA
Gupta Madhur World Health Organization INDIA
Haglelfeg Jesse Department of Health/Yap State Hospital FEDERATED STATES OF MICRONESIA
Hall Sean FIT-BioCeuticals Limited AUSTRALIA
Hansell Lepaitai Samoa National Health Service SAMOA
Hart Judy University of Newcastle AUSTRALIA
Hartayu Titien Sanata Dharma University INDONESIA
Harvey Ken La Trobe University AUSTRALIA
Harvey Jenny Medreach Pty Ltd AUSTRALIA
Hayes Evan FIT-BioCeuticals Limited AUSTRALIA
Heheina Regina Ministry of Health VANUATU
Hemming Mary Therapeutic Guidelines Ltd AUSTRALIA
Hill Suzanne Pharmaceutical Benefits Advisory Committee AUSTRALIA
Hla Thida Ministry of Health MYANMAR
Holbrook Rachel NPS MedicineWise AUSTRALIA
Holloway Kathleen World Health Organization INDIA
Huang Baobin World Health Organization PEOPLE'S REPUBLIC OF CHINA
Hyams Jared La Trobe University AUSTRALIA
Iqbal Javid University of Kashmir INDIA
Islam Qazi Shafayetul BRAC BANGLADESH
Jackson John Pharmaceutical Society of Australia AUSTRALIA
Jair Rosni Ministry of Health BRUNEI DARUSSALAM
Johan Hamid Tengku Bahdar Ministry of Health INDONESIA
Juban Noel University of the Philippines PHILIPPINES
Kafle Kumud The International Network for Rational Use of Drugs NEPAL
Kamowa Dina University of Queensland AUSTRALIA
Karkee Shiba The International Network for Rational Use of Drugs NEPAL
Kaur Shila Health Action International Asia Pacific MALAYSIA
Kaur Inderpal Government Medical College INDIA
Kawashita Norihito Osaka University JAPAN
Kaye Karen NPS MedicineWise AUSTRALIA
KC Santosh Bir Hospital NEPAL
Khan Mohiuddin Kanazawa University JAPAN
Khan Farhan Ahmad Teerthanker Mahaveer Medical College & Research Centre INDIA
Kiatying-Angsulee Niyada Chulalongkorn University THAILAND
Kim Sukyeong Health Insurance Review and Assessment Service REPUBLIC OF KOREA
Kim Daejung Korea Institute for Health and Social Affairs REPUBLIC OF KOREA
Kimura Kazuko Pharmaceutical and Health Science JAPAN
Knight Jo University of Newcastle AUSTRALIA
Kotwani Anita V. P. Chest Institute INDIA
Kumar Sudhir Ministry of Health & Family Welfare INDIA
Kumar Tawa N V R Praveen Deccan School of Pharmacy INDIA
Kwon Soonman Seoul National University REPUBLIC OF KOREA
Kwong Yiu Sum Benjamin Hong Kong Hospital Authority PEOPLE'S REPUBLIC OF CHINA
Lal Joshila Fiji National University FIJI
Lauwo Jackson University of Papua New Guinea PAPUA NEW GUINEA
Lee David Management Sciences for Health USA
Lee Fangchen YungShin Global Holding TAIWAN
Lee See Wing Anna Hong Kong Hospital Authority PEOPLE'S REPUBLIC OF CHINA
Leyesa Normita Federation of Asian Pharmaceutical Associations PHILIPPINES
Lhazeen Karma Ministry of Health BHUTAN
Li Yizhang Peking University People's Hospital PEOPLE'S REPUBLIC OF CHINA
Lim Linda Ying Ying Ministry of Health BRUNEI DARUSSALAM
Lipworth Wendy University of New South Wales AUSTRALIA
Lkhagvadorj Vanchinsuren World Health Organization FIJI
Mackson Judith NSW Ministry of Health AUSTRALIA
Magdalene Engko Sosialine Ministry of Health INDONESIA
Mahe Melenaite Ministry of Health TONGA
Manea Timmy Ministry of Health SOLOMON ISLANDS
Mathias Agnes Ministry of Health VANUATU
Matlab Clarette Ministry of Health PALAU
McEwen John University of Canberra AUSTRALIA
McLachlan Andrew National Medicines Policy Committee AUSTRALIA
Md. Din Rosidah Johor State Health Department MALAYSIA
Mfuko William World Health Organization CAMBODIA
Mocevakaca Leweni Ministry of Health NAURU
Mohamad Dani Pratomo Federation of Asian Pharmaceutical Associations INDONESIA
Murray Mary ReAct – Action on Antibiotic Resistance AUSTRALIA
Newby David University of Newcastle AUSTRALIA
Ng Kwong Allergan AUSTRALIA
Nguyen Connie Tulane School of Public Health USA
Nguyen Tuan Anh University of South Australia AUSTRALIA
Nguyen Thi Lien Huong Hanoi University of Pharmacy VIETNAM
Nguyen Huy Quang Ministry of Health VIETNAM
Norman Lucy Ministry of Health VANUATU
Nosa Manila Niue Health Department NIUE
Nunan Michael AusAID/Solomon Islands Ministry of Health AUSTRALIA
Ocampo Leonila Philippine Pharmacists Association PHILIPPINES
Odaira Koya Kanazawa University JAPAN
O'Keeffe Ellen University of Canberra AUSTRALIA
Or Oudam Roath Department of Drugs and Food CAMBODIA
Othman Nour Hanah Ministry of Health MALAYSIA
Panda Arun Ministry of Health & Family Welfare INDIA
Park Byungjoo Seoul National University Hospital REPUBLIC OF KOREA
Park Muyng-Suk Korean Pharmaceutical Association REPUBLIC OF KOREA
Park Hye-Kyung Korean Pharmaceutical Association REPUBLIC OF KOREA
Park Sun-Im Korea Food and Drug Administration REPUBLIC OF KOREA
Pearce Greg Alphapharm AUSTRALIA
Pearson Sallie University of Sydney AUSTRALIA
Penm Jonathan University of Sydney AUSTRALIA
Pharasi Bada SPS/Management Sciences for Health SOUTH AFRICA
Phillips Susan Therapeutic Guidelines Ltd AUSTRALIA
Phonvisay Bouaphat Ministry of Health LAO PEOPLE'S DEMOCRATIC REPUBLIC
Pratt Nicole University of South Australia AUSTRALIA
Rahman Syed Ziaur Jawaharlal Nehru Medical College INDIA
Rahman Md Sayedur Bangabandhu Sheikh Mujib Medical University BANGLADESH
Rahmawati Riana Islamic University of Indonesia INDONESIA
Rai Manusika AUSTRALIA
Randall Janette NPS MedicineWise AUSTRALIA
Ratanawijitrasin Sauwakon Mahidol University THAILAND
Rawlins Michael National Institute for Health and Care Excellence UNITED KINGDOM
Robertson Jane University of Newcastle AUSTRALIA
Rolan Paul National Medicines Policy Committee AUSTRALIA
Ross-Degnan Dennis Harvard Medical School USA
Roughead Libby University of South Australia AUSTRALIA
Rowett Debra Drug and Therapeutics Information Service AUSTRALIA
Roy Vandana Maulana Azad Medical College INDIA
Roy Debabrata Ministry of Health & Family Welfare INDIA
Rubiyanto Nunut Indonesian Pharmacists Association INDONESIA
Sadasivan Sivalal Monash University MALAYSIA
Sallet Jean-Pierre Management Sciences for Health SOUTH AFRICA
Salole Eugene Pfizer Australia AUSTRALIA
Samunaka Filipo Ministry of Health REPUBLIC OF THE MARSHALL ISLANDS
Sanburg Amanda Ministry of Health VANUATU
Sansom Lloyd University of South Australia AUSTRALIA
Santoso Budiono World Health Organization PHILIPPINES
Selvaraj Sakthivel Public Health Foundation INDIA
Sengupta Amit Peoples Health Movement INDIA
Shirakuni Yuko Osaka University JAPAN
Shrestha Naveen The International Network for Rational Use of Drugs NEPAL
Sia Isidro University of the Philippines PHILIPPINES
Sinclair Paul Pharmacy Guild of Australia AUSTRALIA
Singal Girdhari Lal Food and Drugs Administration INDIA
Singh Jatinder Government Medical College INDIA
Siua Siutaka he Hau Ministry of Health TONGA
Skilling Vita Futalina Department of Health & Social Affairs FEDERATED STATES OF MICRONESIA
Slamet Lucky National Agency of Drug and Food Control INDONESIA
Sless David Communication Research Institute AUSTRALIA
Smith Anthony University of Newcastle AUSTRALIA
Snell Beverley Burnet Institute AUSTRALIA
Sokunna Sau Department of Hospital Service CAMBODIA
Sooja Nam Federation of Asian Pharmaceutical Associations REPUBLIC OF KOREA
Srianujata Songsak Federation of Asian Pharmaceutical Associations THAILAND
Sriphiromya Pakawadee Food and Drug Administration THAILAND
Suleman Fatima University of KwaZulu-Natal SOUTH AFRICA
Sun Jing National Institute of Hospital Administration PEOPLE'S REPUBLIC OF CHINA
Sundararajan Parimalakrishnan Annamalai University INDIA
Suryawati Sri Gadjah Mada University INDONESIA
Syhakhang Lamphone Food and Drug Department LAO PEOPLE'S DEMOCRATIC REPUBLIC
Taakau Ioana Ministry of Health KIRIBATI


Return to: Asia Pacific Conference on National Medicines Policies

Appendix 4: Resources

Access to Medicine Index

The Access to Medicine Index provides a method to monitor and evaluate the performance of the pharmaceutical industry by assessing the output and outcomes of access-to-medicine initiatives. Some of the indicators in this index may be relevant for longitudinal or trend analysis.

The Index includes a range of measures and indicators that assess industry commitment, transparency, performance and innovation (the four strategic pillars) in relation to:

  • general access to medicines management
  • public policy and market influence
  • research and development
  • equitable pricing, manufacturing and distribution
  • patents and licensing
  • capability advancement in product development and distribution
  • product donations and philanthropic activities.

Medicines and Insurance Coverage (MedIC) initiative

The Medicines and Insurance Coverage (MedIC) initiative aims to improve the health of populations by supporting the design, implementation, evaluation, and routine monitoring of evidence-based medicines coverage policies for vulnerable populations across the world. MedIC's goal is to improve the health and economic well-being of people in low and middle income countries by improving availability, affordability, and appropriate use of medicines through health insurance schemes.

WHO Resources

The WHO has a vast library of resources available which can be accessed in a variety of ways. Access the WHO Bookshop and WHO Library database from the Publications tab.

Institutional Repository for Information Sharing (IRIS)

Medicines Publications and Documentation
This site allows searching by title, topic, author, region or country. The public sub-collection tab links to a collection of articles on all aspects of national medicines policies. You can also create your own sub-collection of articles of interest.

Essential Medicines and Health Products Department
This page, with multiple links, identifies the range of work activities undertaken. The medicines topics tab links to an alphabetical index of topics.

Guidelines on the pharmacological treatment of persisting pain in children with medical illnesses
This package consists of four online publications: the WHO guidelines on treating persisting pain in children and three brochures with highlights from the guidelines selected for:

  • physicians and nurses
  • pharmacists
  • policy-makers and medicines regulatory authorities, hospital managers and health insurance managers.

Western Pacific Regional Office

South East Asian Regional Office

International Narcotics Control Board

The International Narcotics Control Board is the independent and quasi-judicial monitoring body for the implementation of the United Nations international drug control conventions. It was established in 1968 in accordance with the Single Convention on Narcotic Drugs, 1961. It had predecessors under the former drug control treaties as far back as the time of the League of Nations. The functions of the Board are laid down in the following treaties:

  • the Single Convention on Narcotic Drugs, 1961
  • the Convention on Psychotropic Substances of 1971
  • the United Nations Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances of 1988.

In the discharge of its responsibilities, the Board:

  • administers a system of estimates for narcotic drugs and a voluntary assessment system for psychotropic substances and monitors licit activities involving drugs through a statistical returns system, with a view to assisting governments in achieving, inter alia, a balance between supply and demand
  • monitors and promotes measures taken by governments to prevent the diversion of substances frequently used in the illicit manufacture of narcotic drugs and psychotropic substances and assesses such substances to determine whether there is a need for changes in the scope of control of Tables I and II of the 1988 Convention
  • analyses information provided by governments, United Nations bodies, specialised agencies or other competent international organisations, with a view to ensuring that the provisions of the international drug control treaties are adequately carried out by governments, and recommends remedial measures
  • maintains a permanent dialogue with governments to assist them in complying with their obligations under the international drug control treaties and, to that end, recommends, where appropriate, technical or financial assistance to be provided.

Regional journals

Southern Medical Review
The Southern Medical Review is published twice a year. It is an open access peer reviewed journal focusing on Pharmaceutical Policy Research. The journal provides a platform for the dissemination of commentary and empirical research findings with a view to improving rational use of and access to essential medicines.

In June 2013, this journal was re-launched as the Journal of Pharmaceutical Policy and Practice (JoPPP), as part of BioMedCentral and is an open access publication. It is relevant to research and practice in low and middle income countries.

The WHO South East Asia Journal of Public Health (WHO SEAJPH)
This is a peer-reviewed, indexed, open access quarterly publication of the World Health Organization Regional Office for South East Asia. The Journal aims to provide an avenue to scientists for publication of original research work so as to facilitate use of research for public health action.

Australian Prescriber
Australian Prescriber is Australia's national independent journal of drugs and therapeutics. Its purpose is to help health professionals make informed choices when prescribing, including whether to prescribe a drug or not. Australian Prescriber provides independent, reliable and accessible information about drugs and therapeutics. As well as publishing short didactic reviews, it facilitates debate about complex, controversial or uncertain therapeutic areas.


Return to: Asia Pacific Conference on National Medicines Policies